Biological Therapy Analysis & Statistics, July 2014 (p9)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

241-270 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Notch Signaling Pathway Inhibitors -Pipeline Insights, 2014

Notch Signaling Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Notch Signaling Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
Integrase Inhibitors -Pipeline Insights, 2014

Integrase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Integrase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2014

Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Interferon Gamma Receptor (IFNGR) Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication, Office Supply and Stationery
Interferon Receptor Binders -Pipeline Insights, 2014

Interferon Receptor Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Interferon Receptor Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug and Medication, Office Supply and Stationery
Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2014

Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Interferon-Alpha/Beta Receptor Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Office Supply and Stationery, Office Goods
Interleukin (IL) Inhibitors -Pipeline Insights, 2014

Interleukin (IL) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Interleukin (IL) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Diagnostics, Diagnostics
Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2014

Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Broad Spectrum Chemokine Inhibitors (BSCIs)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biological Therapy
Anti GM-CSF Antibody -Pipeline Insights, 2014

Anti GM-CSF Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Anti GM-CSF Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical, Biotechnology
Growth Hormone (GH) Agonists -Pipeline Insights, 2014

Growth Hormone (GH) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Growth Hormone (GH) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Biological Therapy
Growth Hormone Antagonists -Pipeline Insights, 2014

Growth Hormone Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Growth Hormone Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Biological Therapy
Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2014

Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Hedgehog Signaling Pathway Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2014

Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Hepatocyte growth factor (HGF) mimetic-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Growth Factor (FGF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Growth Factor Receptor (FGFR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Biological Therapy
Chemokine Receptor Antagonists -Pipeline Insights, 2014

Chemokine Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Chemokine Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
G-CSF Inhibitors -Pipeline Insights, 2014

G-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“G-CSF Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2014

GM-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“GM-CSF Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 ...

  • Industries : Biological Therapy
  • Countries : Europe, World
Global Molecular Diagnostics Market Report: 2014 Edition

Global Molecular Diagnostics Market Report: 2014 Edition

  • $ 800
  • Industry report
  • July 2014
  • by Koncept Analytics

Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological sciences, in particular, have brought forth advancements that rendered ...

  • Industries : Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic
  • Countries : World
Sotio a.s. - Product Pipeline Review - 2014

Sotio a.s. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Sotio a.s. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Sotio a.s. - Product Pipeline Review - 2014’, provides an overview of the Sotio a.s.’s pharmaceutical research and ...

  • Industries : Biological Therapy, Research and Development, Pharmaceutical
  • Countries : Europe, World
GenSight Biologics - Product Pipeline Review - 2014

GenSight Biologics - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

GenSight Biologics - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘GenSight Biologics - Product Pipeline Review - 2014’, provides an overview of the GenSight Biologics’s pharmaceutical ...

  • Industries : Research and Development, Biological Therapy
  • Countries : World

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.